Preoperative oral pentoxifylline in case of coronary artery bypass grafting with left ventricular dysfunction (ejection fraction equal to/less than 30%)
- PMID: 26424631
- PMCID: PMC5368500
- DOI: 10.5152/AnatolJCardiol.2015.6511
Preoperative oral pentoxifylline in case of coronary artery bypass grafting with left ventricular dysfunction (ejection fraction equal to/less than 30%)
Comment on
-
Preoperative oral pentoxifylline in case of coronary artery bypass grafting with left ventricular dysfunction (ejection fraction equal to/less than 30%).Anatol J Cardiol. 2015;15(12):1014-9. doi: 10.5152/akd.2014.5883. Epub 2014 Dec 31. Anatol J Cardiol. 2015. PMID: 25880052 Free PMC article. Clinical Trial.
References
-
- Otani S, Kuinose M, Murakami T, Saito S, Iwagaki H, Tanaka N, et al. Preoperative oral administration of pentoxifylline ameliorates respiratory index after cardiopulmonary bypass through decreased production of IL-6. Acta Med Okayama. 2008;62:69–74. - PubMed
-
- Davi G, Santilli F. Unveiling the inflammatory face of antiplatelet drugs. J Thromb Haemost. 2006;4:2137–9. [CrossRef] - PubMed
-
- Sodha NR, Sellke FW. The effect of statins on perioperative inflammation in cardiac and thoracic surgery. J Thorac Cardiovasc Surg. 2015;149:1495–501. [CrossRef] - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical